This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
While aspiration was not previously addressed head-on in CAP guidelines, new data prompted the 2019 IDSA CAP guideline authors to include the following question: Question 10: In the Inpatient Setting, Should Patients with Suspected Aspiration Pneumonia Receive Additional Anaerobic Coverage beyond Standard Empiric Treatment for CAP?
The VICTOR trial was a randomized international study published in 2007 and showed that success rates for viremia eradication and treatment success were no different between oral or IV therapy at days 21 and 49. However the data these recommendations are based on is extensive and goes back several years.
While aspiration was not previously addressed head-on in CAP guidelines, new data prompted the 2019 IDSA CAP guideline authors to include the following question: Question 10: In the Inpatient Setting, Should Patients with Suspected Aspiration Pneumonia Receive Additional Anaerobic Coverage beyond Standard Empiric Treatment for CAP?
Any special dosing of drugs may also be supported with reasons written on drug charts so that pharmacists at inpatient can take note. External Links Clinical Pharmacy and Therapeutics, 2018 Clinical pharmacy services, pharmacy staffing, and hospital mortality rates, 2007 Drugs stored in the refrigerator should be endorsed "Fridge".
At that time, in 2007, about one-third of hospitals had pharmacists on their resuscitation teams, and this was associated with a statistically significant reduction in patient deaths to the level of 12,880 per year. This is in addition to many other resources to help in your practice.
The Ketogenic Diet for Refractory Mental Illness: A Retrospective Analysis of 31 Inpatients. 2007 Jul;17(7):609-12. [92] Published 2019 Sep 12. doi:10.1038/s41398-019-0559-6 [77] Danan A, Westman EC, Saslow LR, Ede G. Front Psychiatry. 2022;13:951376. Published 2022 Jul 6. doi:10.3389/fpsyt.2022.951376 link] -compulsive-disorder/. [91]
While aspiration was not previously addressed head-on in CAP guidelines, new data prompted the 2019 IDSA CAP guideline authors to include the following question: Question 10: In the Inpatient Setting, Should Patients with Suspected Aspiration Pneumonia Receive Additional Anaerobic Coverage beyond Standard Empiric Treatment for CAP?
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content